Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)
Condition(s):Cutaneous T Cell LymphomaLast Updated:March 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Cutaneous T Cell LymphomaLast Updated:March 31, 2023Completed
Condition(s):Cutaneous T-cell Lymphoma (CTCL)Last Updated:February 28, 2024Active, not recruiting
Condition(s):Cutaneous T Cell Lymphoma; Peripheral T Cell LymphomaLast Updated:May 16, 2017Completed
Condition(s):Cutaneous T Cell LymphomaLast Updated:August 13, 2019Completed
Condition(s):Cutaneous T-Cell LymphomaLast Updated:April 15, 2022Completed
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:September 22, 2022No longer available
Condition(s):Cutaneous T-Cell LymphomaLast Updated:October 19, 2020Completed
Condition(s):Cutaneous T Cell LymphomaLast Updated:February 20, 2024Active, not recruiting
Condition(s):Lymphoma, T-Cell, Cutaneous; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Sezary Syndrome; Lymphoma, Extranodal NK-T-Cell; Lymphoma, B-CellLast Updated:March 31, 2022Recruiting
Condition(s):Cutaneous T Cell Lymphoma; Cutaneous T-Cell Lymphoma/Mycosis Fungoides; Cutaneous T-Cell Lymphoma/Sezary SyndromeLast Updated:November 7, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.